Importance The coronavirus disease 2019 (COVID-19) pandemic prompted policy changes
to allow increased telehealth delivery of buprenorphine, a potentially lifesaving medication …

Despite high mortality rates due to opioid overdose and excessive alcohol consumption,
medications for the treatment of alcohol and opioid use disorder have not been widely used …

Medication treatment (MT) is one of the few evidence-based strategies proposed to combat
the current opioid epidemic. We examined national trends and correlates of offering MT in …

Background A growing body of research has examined adjunctive interventions supportive
of engagement and retention in treatment among patients receiving buprenorphine for …

The US is confronted with a rise in opioid use disorder (OUD), opioid misuse, and opioid-
associated harms. Medication treatment for opioid use disorder (MOUD)—including …

Aims To understand the role of comorbid substance use disorders (SUDs), or polysubstance
use, in the treatment of opioid use disorder (OUD), this study compared patients with OUD …

The essence of “blockchain” is a shared database in which information stored is un-
falsifiable, traceable, open, and transparent. Therefore, to improve the security of private …

Objective: The authors examined the impact of COVID-19-related policies reducing barriers
to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on …

Importance While many individuals with opioid use disorder seek treatment at residential
facilities to initiate long-term recovery, the availability and use of medications for opioid use …

Background Policy evaluations and health system interventions often utilize International
Classification of Diseases (ICD) codes of opioid use, dependence, and abuse to identify …